Komori
Socionext (6526) · InitiativeRestated

Investment in Research and Development

First written in FY2023-Q2. 6 of 10 entries say "Restated". Latest entry: FY2026.

10entries
5years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2023-Q2 – FY2023-Q3RestatedFY2024-Q1 – FY2024-Q3AdvancedFY2024 – FY2025-H1RestatedFY2026-H1 – FY20262022: 12023: 420232024: 320242025: 120252026: 12026
Same theme, other companies
Decline in R&D Expenses with No Change in Activity StatusA theme 44 companies write about · 18 as a headwind · 10 as a tailwind

8 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 44 companies compared. The sentences above are computed from all 44.
Full recordFilings, disclosures and news, newest first
  1. FY2026RestatedAnnual report

    「Research and development expenses for the consolidated fiscal year were ¥58,508 million, down 2.2% from the previous consolidated fiscal year. In advanced development, we actively worked with global ecosystem partners on process technologies, chiplets and advanced packaging technologies, as well as the practical application of the latest design tools and the establishment of development platforms.」

    Research and development expenses declined year on year, but investment in advanced processes, chiplets, advanced packaging and design tools continued at a high level.
  2. FY2026-H1RestatedAnnual report

    「Group-wide research and development expenditure for the interim consolidated fiscal period was ¥28,956 million.」

    Research and development continued, with expenditure of ¥28,956 million for the interim consolidated fiscal period.
  3. FY2025-H1AdvancedAnnual report

    「Research and development expenses for the interim consolidated fiscal period were ¥28,769 million, up 16.8% from the previous interim period. This was mainly because product development for acquired projects increased. In advanced development, we are actively working on process technologies of 2nm and below, advanced packaging technologies such as chiplets, the practical application and platform development of the latest design tools, and other areas through close collaboration with Arm and TSMC to use the latest technologies in the rapidly evolving semiconductor ecosystem.」

    Research and development expenses were ¥28,769 million, up 16.8% year on year, mainly because product development for acquired projects increased. Collaboration with Arm and TSMC and work on 2nm-and-below processes, chiplets and design tools continued.
  4. FY2024AdvancedAnnual report

    「Research and development expenses for the consolidated fiscal year increased 8% from the previous consolidated fiscal year to ¥53,279 million. In advanced development, we actively worked on process technologies of 2nm and below, advanced packaging technologies such as chiplets, and the practical application and platform development of the latest design tools, working closely with our partners to use the latest technologies in the rapidly evolving semiconductor ecosystem.」

    Research and development expenses increased to ¥53,279 million, and work continued on processes of 2nm and below, chiplets and the practical application and platform development of design tools.
  5. FY2024-Q3RestatedAnnual report

    「Group-wide research and development expenditure for the cumulative third quarter of the current consolidated fiscal period was ¥38,255 million.」

    Research and development continued, with expenditure of ¥38,255 million for the cumulative third quarter.
  6. FY2024-Q2RestatedAnnual report

    「Group-wide research and development expenditure for the cumulative second quarter of the current consolidated fiscal period was ¥24,622 million.」

    Research and development continued, with expenditure of ¥24,622 million for the cumulative second quarter.
  7. FY2024-Q1RestatedAnnual report

    「Group-wide research and development expenditure for the cumulative first quarter of the current consolidated fiscal period was ¥12,160 million.」

    Research and development continued, with expenditure of ¥12,160 million for the cumulative first quarter.
  8. FY2023AdvancedAnnual report

    「Research and development expenses for the consolidated fiscal year were ¥49,324 million, up 14.2% from the previous consolidated fiscal year. In advanced development, we actively invested in the practical application and platform development of process technologies finer than 3nm, advanced packaging technologies such as chiplets, and the latest design tools, working closely with our partners to use the latest technologies in the rapidly evolving semiconductor ecosystem.」

    Research and development expenses increased to ¥49,324 million, with specific investment in processes finer than 3nm, chiplets and the practical application and platform development of the latest design tools.
  9. FY2023-Q3RestatedAnnual report

    「Group-wide research and development expenditure for the cumulative third quarter of the current consolidated fiscal period was ¥35,507 million.」

    The group continued investing in research and development, with expenditure of ¥35,507 million for the cumulative third quarter of the current consolidated fiscal period.
  10. FY2023-Q2First statedAnnual report

    「Group-wide research and development expenditure for the cumulative second quarter of the current consolidated fiscal period was ¥22,080 million.」

    Research and development expenditure for the cumulative quarter was ¥22,080 million.
Moved together

"Moving projects using advanced processes of 7nm and below into mass production" moved the same way as this thread, in the same document, in 3 of its 10 moves.

332222★123456
  1. ★This thread
  2. 1Moving projects using advanced processes of 7nm and below into mass production3×
  3. 2Increase in NRE development projects using advanced processes3×
  4. 3Enhancing development competitiveness through standardized development processes, design environments and ecosystem collaboration2×
  5. 4Investment in reticles, test boards, development environments and IP macros2×
  6. 5Focus on 5G networks, automotive and smart devices2×
  7. 6Share issuance and capital increases through the exercise of stock options2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Socionext's next results are scheduled for 2026-10-28. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Investment in Research and Development | Socionext Inc. (6526) | Komori